209 related articles for article (PubMed ID: 29535672)
1. Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China.
Huang X; Li Y; Feng H; Chen P; Liu W
Front Neurol; 2018; 9():77. PubMed ID: 29535672
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features, Treatment, and Prognostic Factors of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort.
Bi Z; Ge H; Zhang Q; Gao H; Yang M; Zhan J; Lin J; Gui M; Li Y; Ji S; Cao Y; Bu B
Pediatr Neurol; 2023 Sep; 146():31-39. PubMed ID: 37421800
[TBL] [Abstract][Full Text] [Related]
3. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
[TBL] [Abstract][Full Text] [Related]
4. Management of Juvenile Myasthenia Gravis.
O'Connell K; Ramdas S; Palace J
Front Neurol; 2020; 11():743. PubMed ID: 32793107
[TBL] [Abstract][Full Text] [Related]
5. Response to treatment in pediatric ocular myasthenia gravis.
Xu L; Castro D; Reisch JS; Iannaccone ST
Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
[TBL] [Abstract][Full Text] [Related]
6. Significance of Acetylcholine Receptor Antibody Titers in Acetylcholine Receptor Antibody-Positive Ocular Myasthenia Gravis: Generalization and Presence of Thyroid Autoimmune Antibodies and Thymoma.
Supawongwattana M; Vanikieti K; Jindahra P; Padungkiatsagul T
Clin Ophthalmol; 2023; 17():649-656. PubMed ID: 36875532
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Ocular Myasthenia Gravis.
Fisher K; Shah V
Curr Treat Options Neurol; 2019 Sep; 21(10):46. PubMed ID: 31559492
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Course and Treatment of a Case of Refractory Systemic Juvenile Myasthenia Gravis Successfully Treated with Thymectomy.
Shibuya M; Shichiji M; Ikeda M; Kodama K; Miyabayashi T; Sato R; Okubo Y; Endo W; Inui T; Togashi N; Nagao M; Sato K; Sato T; Kanzaki M; Segawa O; Masui K; Ishigaki K; Haginoya K
Tohoku J Exp Med; 2024 Jan; 262(1):29-31. PubMed ID: 37967941
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting outcome in ocular myasthenia gravis.
Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
[TBL] [Abstract][Full Text] [Related]
10. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate.
Li F; Li Z; Chen Y; Bauer G; Uluk D; Elsner A; Swierzy M; Ismail M; Meisel A; Rückert JC
Eur J Cardiothorac Surg; 2020 Mar; 57(3):478-487. PubMed ID: 31628812
[TBL] [Abstract][Full Text] [Related]
11. Ocular myasthenia gravis - How effective is low dose prednisone long term?
Verma R; Wolfe GI; Kupersmith MJ
J Neurol Sci; 2021 Jan; 420():117274. PubMed ID: 33360170
[TBL] [Abstract][Full Text] [Related]
12. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
13. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy.
Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H
Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
Yan C; Zhao R; Song J; Feng X; Xi J; Luo S; Zhong H; Zhou S; Li W; Zhao C
J Neuroimmunol; 2020 Dec; 349():577403. PubMed ID: 32992216
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of Ocular Myasthenia Gravis in an Argentinian Population.
Aguirre F; Villa AM
Eur Neurol; 2018; 79(3-4):113-117. PubMed ID: 29428956
[TBL] [Abstract][Full Text] [Related]
16. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
[TBL] [Abstract][Full Text] [Related]
17. Juvenile myasthenia gravis: a twenty-year experience.
Castro D; Derisavifard S; Anderson M; Greene M; Iannaccone S
J Clin Neuromuscul Dis; 2013 Mar; 14(3):95-102. PubMed ID: 23492460
[TBL] [Abstract][Full Text] [Related]
18. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis.
Bi Z; Zhan J; Zhang Q; Gao H; Yang M; Ge H; Gui M; Lin J; Bu B
Front Immunol; 2023; 14():1177249. PubMed ID: 37266422
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestation and generalization after ocular onset in ocular myasthenia gravis: A 5-year analysis.
Kemchoknatee P; Arepagorn A; Srisombut T
Asian Pac J Allergy Immunol; 2021 Oct; ():. PubMed ID: 34717528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
